Fabtech Technologies IPO listed at an 0.52% premium on NSE at ₹192 and BSE at ₹191.

Fabtech Technologies IPO is listed with a premium of 0.52% on the BSE ₹191 (Bombay Stock Exchange) and on NSE (National Stock Exchange) at ₹192. The IPO GMP of this IPO was ₹0 last heard.

Table of Contents

Fabtech Technologies IPO was subscribed overall 2.04 times on the last day, while the retail quota was subscribed 2.09 times, QIB was subscribed 2.02 times, and NII quota subscribed by 1.97 times, respectively. 

Details About Fabtech Technologies IPO

Fabtech Technologies got approval from SEBI for an IPO of ₹230.35 crores .In this IPO, a fresh issue of ₹230.35 crores with a face value of ₹10 each. 

Moreover, the company has set up a price band between ₹181 to ₹191  per share. In this IPO, 75 shares were available in 1 lot size for the minimum retail category, 975 shares in 13 lot sizes for the maximum retail category.

 and a total of 1,050 shares in 14 lot sizes for S-HNI (Min) and 5,175 shares in 69 lot sizes for SHNI (Max). B-HNI 5,250 shares in 70 lot sizes. 

To invest in this IPO, each investor category has specific investment amounts:

  • Retail Investors: Minimum investment of ₹14,325 and maximum investment of ₹1,86,225.
  • Small HNI (S-HNI): Minimum investment of ₹2,00,550. 
  • S-HNI: (maximum) investment of ₹9,88,425. 
  • B-HNI (B-HNI): Minimum investment of ₹10,02,750. 

Subscription duration of Fabtech Technologies IPO

The Fabtech Technologies IPO subscription opening date was September 29, 2025, and closed on October 1, 2025. The Fabtech Technologies IPO allotment was finalized on October 3, 2025, and the IPO listing is on October 7, 2025. 

Funds Deployment of This Company 

  • Some funds from the fresh issue will be utilized for Funding working capital requirements of the Company. 
  • Some proceeds will be used for the Pursuing inorganic growth initiatives through acquisitions. 
  • Lastly, the remaining funds will be used for General Corporate Purpose. 

About Fabtech Technologies IPO

Fabtech Technologies Limited, founded in 2018, is a growing company in biopharma engineering. It provides complete project solutions, including cleanroom facilities, modular systems, and custom engineering services.

They operate in over 62 countries across the Middle East, Africa, Asia, Europe, Latin America, and North America, with presence in key markets like India, the USA, the UAE, Saudi Arabia, Egypt, Kenya, Nigeria, and South Africa.

Moreover, the company also offers a wide range of equipment for purified water, pure steam, and water for injections, with flow rates from 500 LPH to 50,000 LPH. The company serves the Life sciences, food & beverage, IT, semiconductor, and aeronautics industries. The company includes 185 permanent employees as of July 31, 2025.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.